| ADAPTIVE BIOTECHNOLOGIES |
| USA |
| Gesundheit |
| US00650F1093 / A2PLR5 |
| 1HM (Frankfurt) / ADPT (NASDAQ) |
| FRA:1HM, ETR:1HM, 1HM:GR, NASDAQ:ADPT |
| - |
| https://www.adaptivebiote.. |
|
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company that develops an immune medicine platform for diagnosing and treating various diseases. The company's core offering is its immunosequencing platform, which uses propriet..
>Volltext.. |
| 2952.47 Mio. EUR |
| 2950.51 Mio. EUR |
| 258.77 Mio. EUR |
| -25.22 Mio. EUR |
| -43.52 Mio. EUR |
| -0.28 EUR |
| 182.36 Mio. EUR |
| 67.96 Mio. EUR |
| -23.69 Mio. EUR |
| 2.51 |
| 45.95% |
| 67.2% |
| - |
| - |
| - |
| 5 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 15.127.499 Euro. |
| ADAPTIVE BIOTECHNOLOGIES, ADAPTIVE BIO, ADAPTIVE BIOTECH |
| 12.07.26 |